Technical Analysis for NVCR - NovoCure Limited

Grade Last Price % Change Price Change
C 16.86 2.31% 0.38
NVCR closed up 2.31 percent on Wednesday, November 20, 2024, on 67 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
50 DMA Resistance Bearish 2.31%
Bullish Engulfing Bullish 2.31%
Bollinger Band Squeeze Range Contraction 2.31%
Outside Day Range Expansion 2.31%
Bollinger Band Squeeze Range Contraction 7.18%
NR7 Range Contraction 7.18%

   Recent Intraday Alerts

Alert Time
20 DMA Resistance about 20 hours ago
200 DMA Resistance about 21 hours ago
10 DMA Resistance about 21 hours ago
Up 5% about 21 hours ago
Rose Above 200 DMA about 21 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NovoCure Limited develops and commercializes treatment for solid tumor cancers therapy called the tumor treating fields (TTFields). The company markets its proprietary therapy, TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer. NovoCure Limited also conducts clinical trials for the use of TTFields in brain metastases, advanced non-small cell lung cancer, pancreatic cancer, ovarian cancer, and mesothelioma. The company markets its products in the United States, as well as in European Union member states, Switzerland, and Japan. NovoCure Limited was founded in 2000 and is based in Saint Helier, Channel Islands.
Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Cancer Clinical Medicine Oncology Tumor Non Small Cell Lung Cancer Ovarian Cancer Pancreatic Cancer Small Cell Lung Cancer Blastoma Glioblastoma Brain Tumor Solid Tumor Cancers Aging Associated Diseases Brain Cancer Metastases Mesothelioma

Is NVCR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 24.735
52 Week Low 11.31
Average Volume 1,008,397
200-Day Moving Average 17.10
50-Day Moving Average 16.52
20-Day Moving Average 16.85
10-Day Moving Average 17.07
Average True Range 1.08
RSI (14) 50.74
ADX 19.34
+DI 26.92
-DI 19.52
Chandelier Exit (Long, 3 ATRs) 15.42
Chandelier Exit (Short, 3 ATRs) 18.35
Upper Bollinger Bands 18.40
Lower Bollinger Band 15.30
Percent B (%b) 0.5
BandWidth 18.43
MACD Line 0.04
MACD Signal Line 0.13
MACD Histogram -0.097
Fundamentals Value
Market Cap 1.8 Billion
Num Shares 107 Million
EPS -1.86
Price-to-Earnings (P/E) Ratio -9.06
Price-to-Sales 3.35
Price-to-Book 4.16
PEG Ratio -0.47
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.56
Resistance 3 (R3) 18.53 17.94 18.27
Resistance 2 (R2) 17.94 17.51 17.95 18.18
Resistance 1 (R1) 17.40 17.24 17.67 17.43 18.08
Pivot Point 16.81 16.81 16.95 16.82 16.81
Support 1 (S1) 16.27 16.38 16.54 16.30 15.64
Support 2 (S2) 15.68 16.11 15.69 15.54
Support 3 (S3) 15.14 15.68 15.45
Support 4 (S4) 15.17